Edition:
United States

Microbot Medical Inc (MBOT.OQ)

MBOT.OQ on NASDAQ Stock Exchange Capital Market

1.05USD
14 Dec 2017
Change (% chg)

$0.03 (+2.94%)
Prev Close
$1.02
Open
$1.11
Day's High
$1.16
Day's Low
$1.05
Volume
496,897
Avg. Vol
186,384
52-wk High
$9.94
52-wk Low
$1.00

Chart for

About

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.49
Market Cap(Mil.): $40.54
Shares Outstanding(Mil.): 38.61
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 190.77 15.47
EPS (TTM): -- -- --
ROI: -- -11.61 33.71
ROE: -- -35.87 16.38

BRIEF-Microbot Medical Says ‍U.S. Patent And Trademark Office Issued A Notice Of Allowance Covering Company's Tipcat Technology Platform​

* MICROBOT MEDICAL INC - ‍U.S. PATENT AND TRADEMARK OFFICE ISSUED A NOTICE OF ALLOWANCE COVERING COMPANY'S TIPCAT TECHNOLOGY PLATFORM​ Source text for Eikon: Further company coverage:

Dec 14 2017

BRIEF-Microbot Medical receives additional government grant for development of its self-cleaning shunt

* Microbot Medical Inc receives additional government grant for development of its self-cleaning shunt Source text for Eikon: Further company coverage:

Nov 08 2017

BRIEF-Microbot Medical Q2 loss per share $0.12

* Microbot Medical Inc reports second quarter 2017 financial results and recent development and strategic progress

Aug 14 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.85 --
Pfizer Inc. (PFE.N) $36.46 -0.18
Roche Holding Ltd. (ROG.S) CHF241.70 0.00
Roche Holding Ltd. (RO.S) CHF242.50 -0.70
Merck & Co., Inc. (MRK.N) $56.01 -0.90
Sanofi SA (SASY.PA) €73.77 -0.89
Abbott Laboratories (ABT.N) $54.73 -0.33
Amgen, Inc. (AMGN.OQ) $174.92 -2.46
Merck KGaA (MRCG.DE) €90.05 --
Biogen Inc (BIIB.OQ) $323.55 -7.16

Earnings vs. Estimates